Home
Zambon Group SpA

Zambon Group SpA Market Share Analysis for November 2025

the zambon group is characterized by strong focus on quality in the production of medicines and research and development in specific therapeutic areas of excellence.

Health > Biotechnology and Pharmaceuticals

Domainzambongroup.com

Year Founded--

Employees1001 - 5000

Annual Revenue$500M - $1B

Zambon Group SpA

Zambon Group SpA (including company regionals)

zambongroup.com

See more website traffic and engagement information

Zambon Group SpA Revenue up to November 2025 is 500M - 1B

revenue generated by Zambon Group SpA top domains

Zambon Group SpA top domains revenue over 3 years

Revenue for Zambon Group SpA top domains

zambongroup.com500M - 1B

See more with Sales Intelligence

Total visits to Zambon Group SpA's top domains

Understand Zambon Group SpA market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

zambongroup.com46

See more with Sales Intelligence

Avg. visit duration in Zambon Group SpA's top domains

Analyze Zambon Group SpA engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Zambon Group SpA's top domains

See how Zambon Group SpA keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

zambongroup.com1.01

See more with Sales Intelligence

Zambon Group SpA top competitors by domain

Top similar sites in November 2025, ranked by their affinity

veronapharma.comCompany NameVerona PharmaEmployees201 - 500HQUnited Kingdom, LondonAnnual revenue$200M - $500MTotal visits7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Zambon Group SpA

These are the website technologies, by industry, used by Zambon Group SpA top domains

Advertising (2)

PubMatic

Content Management System (2)

Drupal

Social (2)

Instagram

Conversion & Analytics (1)

Google Analytics

More Technologies

7

See all

News & Signals from Zambon Group SpA

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAdven Group partnered with Zambongroup on Jun 29th '21.Curaleaf Holdings Inc (OTCMKTS: CURLF) has announced that its wholly-owned subsidiary, Adven GmbH, has entered into a planned Collaboration with Zambon GmbH, the German subsidiary of Zambon Spa.

NewsNewron Pharmaceuticals S.p.A. sells assets to Zambongroup.Zambon acquired rights from Newron Pharmaceuticals ( www.newron.com ) to develop and commercialize Xadago® globally, excluding Japan and other key Asian territories where Meiji Seika Pharma has the rights to develop and commercialize safinamide.

NewsCuraleaf Holdings, Inc. partnered with Zambongroup on Jun 1st '19.In June Curaleaf International announced it has gained accessibility of medical cannabis products in Germany with a strategic partnership with its wholly-owned subsidiary and Zambon GmbH.